Longeveron Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Name: Longeveron Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Longeveron Inc - Ordinary Shares - Class A
Rating: 1.58600
Author: Trendlyne DVM scores

about

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation so...

1.46 -0.01 (-0.68%)

70.08% Fall from 52W High

104.9K

XNAS Volume

XNAS 16 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

17.5 / 100

Technically Neutral

45.9 / 100

1Yr Price target upside is 509%

4 analysts

Longeveron Inc - Ordinary ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Longeveron Inc - Ordinary Shares - Class A Live Share Price Today, Share Analysis and Chart

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation so...

70.08% Fall from 52W High

SWOT Analysis

Longeveron Inc - Ordinary ... Live Price Chart